Anxiety, Depression, and Sleep Disturbances in Patients with Liver Cirrhosis: Associations with Disease Severity
Aim: Depression and sleep disturbances are common but often overlooked complications in patients with liver cirrhosis. We aimed to determine the prevalence of anxiety, depression, and sleep disturbances in patients with liver cirrhosis and to investigate their association with disease severity. Methods: This cross-sectional study enrolled 115 patients with cirrhosis and 207 healthy volunteers, all recruited between October 2022 and June 2023. Sociodemographic characteristics (age, gender, marital status, smoking and alcohol use, income, and education level), medical history, and laboratory findings were recorded. Disease severity was evaluated using the Child-Pugh and MELD-Na scoring systems. The Hospital Anxiety and Depression Scale (HADS) and the Pittsburgh Sleep Quality Index (PSQI) were used to assess anxiety, depression, and sleep disturbances. Statistical comparisons were performed using the Mann-Whitney U test, the chi-square test, and the Spearman correlation analysis. Results: Patients with liver cirrhosis had significantly higher median HADS-Anxiety scores [13 (8-17) vs. 5 (4-7), p<0.001], HADS-Depression scores [12 (9-16) vs. 4 (3-6), p<0.001], and PSQI scores [11 (6-14) vs. 5 (4-7), p<0.001] compared with controls. Anxiety was present in 64.3% of patients versus 3.4% of controls (p<0.001); depression in 66% of patients versus 1.9% of controls (p<0.001); and poor sleep quality in 85.2% of patients versus 47.8% of controls (p<0.001). Significant positive correlations were observed between HADS-Anxiety and MELD-Na scores and between HADS-Depression and PSQI scores and both MELD-Na and Child-Pugh scores. No statistically significant correlation was found between HADS-Anxiety and Child-Pugh scores (p=0.056). Conclusion: Anxiety, depression, and sleep disturbances are highly prevalent among patients with cirrhosis and are associated with disease severity. Routine psychological assessment and timely intervention may improve patients’ quality of life and clinical outcomes.
Authors
- Alpaslan Tanoğlu (ORCID: https://orcid.org/0000-0002-7477-6640)
- Mustafa Can Şenoymak (ORCID: https://orcid.org/0000-0002-1977-5127)
- Süleyman Baş (ORCID: https://orcid.org/0000-0002-5883-445X)
- Murat Yeniçeri (ORCID: https://orcid.org/0000-0003-3046-5784)
- Zeynep Busra Akin
Institutions
- Bahçeşehir University (TR)
- Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Medical Bulletin of Haseki
- Published
- 2026-11-17
- DOI
- https://doi.org/10.4274/haseki.galenos.2026.46036
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00